Indefinite Delivery Contract 75N93025D00014
Award Date
9/15/25
Last Date to Order
9/14/32
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Sri International
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The National Institute of Allergy and Infectious Diseases has awarded an Indefinite Delivery/Indefinite Quantity contract to Sri International to support medical countermeasure development efforts. Task orders issued to date involve animal model development, efficacy testing, and clinical safety studies for monoclonal antibodies, vaccines, and therapeutics against infectious disease targets. Work is conducted at Sri International's facility in West Menlo Park, California over periods ranging...
The federal contract IDV is an Indefinite Delivery Contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the non-profit research and development organization SRI International. The single-award contract has a $50,000,000.00 ceiling value and a performance period through September 14, 2032. The contract is for INTERVENTIONAL AGENTS CHEMISTRY SERVICES, providing SRI International's specialized research and technical capabilities to the...
This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract has a total ceiling value of $50,000,000 and a period of performance ending on September 14, 2032. The prime contractor is Research Triangle Institute (RTI International), a non-profit research organization headquartered in North Carolina. The contract is intended to provide NIAID with...
The National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services' National Institutes of Health, awarded a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract to provide preclinical development support for candidate products and drug development activities. The contract, with a ceiling value of $107,274,471 and a 7-year period of performance from October 2020 to October 2027, covers a range of services including in...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded Sri International a multiple award indefinite delivery contract to provide resources advancing pediatrics and HIV prevention science. Valued at up to $98.8 million over seven years, the contract aims to support preclinical gap filling, animal model studies, bioanalytical services, product manufacturing, and scientific/quality assistance. Sri International has also received a $45,041 delivery order...
This indefinite delivery contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Sri International, a non-profit research and development organization. The contract, with a ceiling value of $9,900,000, has an ultimate completion date of September 26, 2028. The purpose of this IDC is to obtain research and development services to support preclinical pharmacokinetic and pharmacology evaluations of agents being...
This Indefinite Delivery Contract (IDC) is a single-award contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Sri International, a non-profit research and development organization. The contract, valued at a ceiling of $342,897, is for the provision of IN VITRO METABOLISM AND NON-CLINICAL ADME STUDIES over a 5-year period of performance from September 27, 2021 to April 25, 2025. The contract was not set aside for any specific business size or socioeconomic...
This indefinite delivery contract was awarded by the National Cancer Institute, a component of the U.S. Department of Health and Human Services, to the non-profit research and development institute SRI International. The single-award contract, valued at a ceiling of $12,069,385, is for the analysis and synthesis of GMP and non-GMP bulk drugs and pharmaceutical formulations. With a period of performance running through April 2028, this contract enables the National Cancer Institute to efficiently...
This indefinite delivery contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Sri International, a non-profit research institute. The $3.9 million contract supports NCATS' drug development programs by (1) developing and validating sensitive bioanalytical methods to quantify concentrations of novel biologics, (2) developing assays to measure anti-drug antibodies, and (3)...
This indefinite delivery contract, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. federal government, aims to provide the capability and capacity to develop and employ animal and animal replacement models of infectious diseases for screening, product evaluation, and eventual clinical evaluation. The single-award contract, with a 7-year ordering period and a ceiling value of $146.3 million, was awarded to Sigmovir Biosystems, Inc., a...